This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Owens, D. S. Articles by Plehn, J. F. Search for Related Content PubMed PubMed Citation Articles by Owens, D. S. Articles by Plehn, J. F. Related Collections Congestive Risk Factors Imaging Echocardiography Chronic ischemic heart disease Epidemiology

(Circulation. 2007;116:126-130.)
© 2007 American Heart Association, Inc.

Editorial

Recognizing Unrecognized Risk

The Evolving Role of Ventricular Functional Assessment in Population-Based Studies

David S. Owens, MD; Jonathan F. Plehn, MD

From the Divisions of Cardiology, University of Washington, Seattle (D.S.O.); George Washington University, Washington, DC (J.F.P.); and the Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Md (D.S.O., J.F.P.).

Correspondence to Jonathan F. Plehn, MD, Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Building 10, CRC 5-5330, 10 Center Dr, Bethesda, MD 20892. E-mail plehnj@nhlbi.nih.gov

Key Words: Editorials • coronary diseases • echocardiography • epidemiology • imaging • risk factors

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The rapid evolution of advanced cardiac imaging technologies has resulted in enhanced detection of subclinical disease with the potential for early implementation of therapeutic strategies and reduction in subsequent morbidity and mortality. Noninvasive assessment of ventricular function can provide evidence of prevalent coronary artery disease and cardiomyopathy and could supplant electrocardiography (ECG), the traditional marker of unrecognized myocardial infarction (UMI), in population screening. An appreciation of past efforts in this field is useful in understanding the potential future trajectories of these technologies.

Article p 143

	Unrecognized Myocardial Infarction

 
Ever since Herrick’s initial description of classic angina in 1912, it has been known that incident myocardial infarction (MI) will go unrecognized in a substantial portion of the population. Patients with UMI either recall symptoms that are atypical of MI or have no recollection of any event at all. Initially, autopsy findings and, later, ECG evidence indicated that "silent" MIs were frequent in hospitalized populations. These observations were later extended to a free-living cohort with the first epidemiological data reported from the Framingham Heart Study in 1959 by Stokes and Dawber.¹ These investigators noted that 21% of subjects with new ECG-documented MI on biennial serial examinations had either atypical symptoms that were not clearly related to MI or no apparent ischemia-related complaints. Kannel and Abbott² later observed that new Q-wave infarctions detected on biennial Framingham examinations over a 30-year follow-up period were unknown to 28% of the men and 35% of the women who experienced them, with approximately half of these MIs unaccompanied by discernible . . . [Full Text of this Article]